Roche Canada is committed to providing timely information to support our healthcare practitioner community as it relates to COVID-19.  

This public health emergency of international concern is a prioritized area of attention for all of us and we greatly appreciate your efforts as the front-line workers supporting patients in this challenging situation. We are closely monitoring the evolving COVID-19 pandemic and following the guidance provided by public health officials, and will continue to keep you updated.

This site is intended to provide Canadian Healthcare Professionals with the latest information regarding Roche Canada products and services during COVID-19. 

Within this site, HCPs will find the following information and resources: 

  • Information for Healthcare Professionals and Guidance

  • Frequently asked Questions 

  • Infusion Clinic Status

  • Useful Resources: COVID-19

  • Roche Data Science Coalition 

  • Contact Us 



The site will be updated on a consistent basis with relevant news and additional content.

Information regarding the Roche Data Science Coalition’s efforts to support the HCP community through a patient self-assessment tool can be found below.

Frequently Asked Questions 

The following section provides answers to frequently asked questions. Questions not covered in the following section can be addressed by contacting us using the information at the bottom of this page.

Is the quality of Roche products impacted by COVID-19? What is your approach to ensuring the safety of medicine manufacturing at this time?

All of our manufacturing facilities comply with current Good Manufacturing Practice regulations, which include hygiene standards to safeguard against potential contamination or cross-contamination and mandatory requirements to report any issues.

To safeguard our employees and operations, all Roche manufacturing sites have site-specific pandemic plans in place to ensure business continuity to the best of their ability during this ongoing health situation. We are monitoring the situation closely in real-time across our global manufacturing network, and we are confident that we are taking all appropriate steps to minimize infection risks.

Infusion Clinic Status

At Roche Canada, our aim is to ensure that every person who needs our medicines is able to access them through our Patient Support Programs. 

We are working proactively with all of our associated clinics to keep patients as safe as possible when receiving Roche therapy through our programs, and taking active measures to ensure the ongoing administration of our medications to all of our Canadian patients. For more information please see our Patient Assistance Program Health & Safety Update.

Given the rapidly evolving and escalating health authority guidance and in the interests of the health and safety of their patients and staff, private infusion clinics may make the decision to close.  Should this occur, our vendor network will assess all impacted patients and offer an appropriate alternative setting on a priority basis. If you have questions, please contact the program directly.

Roche understands that many patients and their families have been financially impacted by the COVID-19 pandemic. If you currently have patients who are enrolled in a Roche Patient Assistance Program and have lost their job or health insurance coverage due to the COVID-19 pandemic, we will continue to work with both public and private payers to find solutions that ensure they have continuity of therapy, and we will close the gap when needed.

For updated private and public payor information related to COVID-19, please see our COVID-19 Payor Tracker_2020May8. Content will be updated weekly.